Health insurance type moderates the association between substance use disorders and cardiovascular multimorbidity among U.S. adults - Results from the 2023 National Survey on Drug use and Health

Subst Abuse Treat Prev Policy. 2026 May 7;21(1):33. doi: 10.1186/s13011-026-00705-w.ABSTRACTBACKGROUND: Cardiovascular multimorbidity (CVD MM), defined as two or more cardiovascular conditions, poses a significant public health challenge. Substance use disorders (SUDs) may elevate CVD MM risk, and h

K Kevin M Ball

Comparative evaluation of knowledge levels and attitudes regarding periodontal health and periodontal disease among internal medicine physicians and dentists in Turkey: a cross-sectional survey study

BMC Med Educ. 2026 May 7. doi: 10.1186/s12909-026-09365-7. Online ahead of print.ABSTRACTBACKGROUND: Periodontal diseases are closely related to various systemic conditions including diabetes mellitus (DM), cardiovascular diseases, adverse pregnancy outcomes, and rheumatoid arthritis (RA). Internal

B Beyza Bozmaoğlu

Associations between lifestyle and initiation of cardiovascular preventive medicines in 60-year-olds at low to moderate cardiovascular risk level - a prospective cohort study based on the VIPVIZA-trial

BMC Cardiovasc Disord. 2026 May 7. doi: 10.1186/s12872-026-05922-6. Online ahead of print.ABSTRACTBACKGROUND: Medicines complement healthy lifestyles in cardiovascular disease (CVD) prevention, but knowledge is lacking on how behaviours in these domains are related. This study aimed at investigating

T Tove Lindström Lundgren

Thrombolysis in spinal cord infarction: Case report and systematic review

Neurol Sci. 2026 May 8;47(6):478. doi: 10.1007/s10072-026-09085-2.ABSTRACTINTRODUCTION: Spinal cord infarction (SCI) is a rare but severe cause of acute myelopathy, and evidence supporting reperfusion therapies remains limited.METHODS: We report a 73-year-old man with spontaneous cervical SCI treate

A Andrea Di Pietro

Epidemiology of cardiovascular-kidney-metabolic syndrome

Nat Rev Nephrol. 2026 May 7. doi: 10.1038/s41581-026-01078-w. Online ahead of print.ABSTRACTCardiovascular-kidney-metabolic (CKM) syndrome, defined by the American Heart Association in 2023, describes the interconnected risks of metabolic dysfunction, chronic kidney disease and cardiovascular diseas

L Lucas A Mavromatis